- Report
- February 2026
- 180 Pages
North America
From €6594EUR$7,250USD£5,637GBP
- Report
- January 2026
- 120 Pages
North America
From €5412EUR$5,950USD£4,626GBP
- Report
- September 2025
- 80 Pages
Middle East
From €5412EUR$5,950USD£4,626GBP
- Report
- September 2025
- 125 Pages
Middle East
From €3866EUR$4,250USD£3,304GBP
- Report
- April 2026
- 200 Pages
United States
From €2720EUR$2,990USD£2,325GBP
- Report
- September 2025
- 120 Pages
United States
From €3593EUR$3,950USD£3,071GBP
- Report
- July 2025
- 250 Pages
Africa, Middle East
From €3519EUR$3,869USD£3,008GBP
- Report
- July 2025
- 250 Pages
Latin America
From €3519EUR$3,869USD£3,008GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3519EUR$3,869USD£3,008GBP
- Report
- July 2025
- 250 Pages
North America
From €3519EUR$3,869USD£3,008GBP
- Report
- July 2025
- 250 Pages
Europe
From €3519EUR$3,869USD£3,008GBP
- Report
- July 2025
- 250 Pages
Latin America
From €3519EUR$3,869USD£3,008GBP
- Report
- April 2026
- 148 Pages
Middle East
From €2728EUR$2,999USD£2,332GBP
€3637EUR$3,999USD£3,109GBP
- Report
- March 2026
- 139 Pages
United States
From €2728EUR$2,999USD£2,332GBP
€3637EUR$3,999USD£3,109GBP
- Report
- May 2026
- 180 Pages
United States
From €4320EUR$4,750USD£3,693GBP
- Report
- July 2025
- 250 Pages
North America
From €3519EUR$3,869USD£3,008GBP
- Report
- July 2026
Europe
From €3629EUR$3,990USD£3,102GBP
- Report
- January 2026
- 160 Pages
Latin America
From €2874EUR$3,160USD£2,457GBP
€3593EUR$3,950USD£3,071GBP
- Report
- February 2026
- 108 Pages
Europe
From €5453EUR$5,995USD£4,661GBP
- Report
- February 2026
- 85 Pages
North America
From €5453EUR$5,995USD£4,661GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more